This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1974 Jan;30(1):68-73.

doi: 10.1093/oxfordjournals.bmb.a071170.

Radioimmunoassay and saturation analysis. Tumor-associated antigens

PMID: 4143181
DOI: 10.1093/oxfordjournals.bmb.a071170

Radioimmunoassay and saturation analysis. Tumor-associated antigens

K D Bagshawe. Br Med Bull. 1974 Jan.

. 1974 Jan;30(1):68-73.

doi: 10.1093/oxfordjournals.bmb.a071170.

Author

PMID: 4143181
DOI: 10.1093/oxfordjournals.bmb.a071170

No abstract available

PubMed Disclaimer

Similar articles

Biological markers in gynecologic cancers. An overview.
Dini MM, Miller M. Dini MM, et al. IMJ Ill Med J. 1984 Sep;166(3):166-71. IMJ Ill Med J. 1984. PMID: 6208177 No abstract available.
Tumour antigens associated with primary mediastinal choriocarcinoma.
Forest JC, Talbot J, Pagé M, Loiselle JM. Forest JC, et al. Can Med Assoc J. 1977 Dec 17;117(12):1386-8. Can Med Assoc J. 1977. PMID: 73406 Free PMC article.
Tumour markers in urology: aids in cancer diagnosis and management.
Wahren B. Wahren B. Urol Res. 1979 Jun 22;7(2):57-67. doi: 10.1007/BF00254682. Urol Res. 1979. PMID: 89748 No abstract available.
Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S, Miyake H. Yamauchi S, et al. Kitasato Arch Exp Med. 1988 Sep;61(2-3):95-109. Kitasato Arch Exp Med. 1988. PMID: 2463397 Review. No abstract available.
[Significance of tumor markers in clinical oncology].
Gericke D, Drahovsky D. Gericke D, et al. Med Klin. 1979 May 11;74(19):701-9. Med Klin. 1979. PMID: 88005 Review. German. No abstract available.

See all similar articles

Cited by

[Pregnancy-specific and pregnancy-associated proteins for diagnosing and monitoring malignant disease (author's transl)].
Bauer HW, Bohn H. Bauer HW, et al. Klin Wochenschr. 1978 Jun 1;56(11):531-7. doi: 10.1007/BF01477248. Klin Wochenschr. 1978. PMID: 77934 Review. German. No abstract available.
Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
Jenssen HL, Köhler H, Günther J, Klausch B, Straube W, Hofmann R, Büttner HH. Jenssen HL, et al. Arch Gynakol. 1976 Mar 5;220(3):191-8. doi: 10.1007/BF00667747. Arch Gynakol. 1976. PMID: 773334
Tumour markers in breast cancer.
Cove DH, Woods KL, Smith SC, Burnett D, Leonard J, Grieve RJ, Howell A. Cove DH, et al. Br J Cancer. 1979 Nov;40(5):710-8. doi: 10.1038/bjc.1979.251. Br J Cancer. 1979. PMID: 92331 Free PMC article.
Editorial: Ectopic secretion by tumours.
[No authors listed] [No authors listed] Br Med J. 1976 May 29;1(6021):1300-1. Br Med J. 1976. PMID: 178403 Free PMC article. No abstract available.
Serum proteins as tumour markers for breast cancer.
Mattison P, Cove DH, Walsh L, Howell A, McConkey B, Morrison JM. Mattison P, et al. Br J Cancer. 1981 Apr;43(4):542-5. doi: 10.1038/bjc.1981.78. Br J Cancer. 1981. PMID: 6972225 Free PMC article. No abstract available.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems